GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

iZafe Group IZAFE B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.20

-11.11%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About iZafe Group

Its shares trade on Nasdaq Stockholm under the ticker IZAFE B.ST. It has been listed since 4 April 2011. In the fiscal year to 31 December 2025, it reported revenue of SEK 6.0m and a net loss of SEK 16.7m. At that date it held total assets of SEK 35.6m and shareholders' equity of SEK 11.7m.

iZafe Group AB is a medical technology company, which engages in the research, development, and marketing of medical and digital security solutions. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2011-04-04. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The firm operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. The company is active globally.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
4 Apr 2011
Employees
11
Website
izafe.se ↗

Leadership

Pay as last reported

  • Mr. Richard WolffIndependent Chairman of the Board
  • Mr. Anders SegerstromChief Executive Officer
  • Mr. Tobias JohanssonDeputy Chief Executive Officer, Director of Sales
  • Mr. Goran HermansonChief Operating Officer, since 2019
  • Mr. Carl-fredrik BothenChief Marketing Officer
  • Mr. Samuel DanofskyDirector
  • Ms. Anna HakanssonDirector
  • Ms. Jenny StyrenIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • iZafe Group AB's Dosell drug dispenser offers remote monitoring for home medication management.
  • MediKoll app provides real-time medication side effect information for patients globally.
  • The company operates in pharmaceutical, hospital, and care home markets with 11 employees.

Weaknesses

  • iZafe Group AB has only 11 employees, limiting operational capacity.
  • The company's IPO in 2011 may indicate limited market traction.
  • Dosell is still under development, delaying full market entry.

Opportunities

  • Global expansion into pharmacies and private healthcare markets presents growth potential.
  • Digital security solutions in healthcare can attract new partnerships.
  • Remote monitoring technology aligns with increasing telehealth trends.

Threats

  • Competition in the medical technology sector could impact market share.
  • Regulatory changes in healthcare may affect product approvals.
  • Dependence on developing Dosell could delay revenue generation.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.